Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00004314
Other study ID # 199/11823
Secondary ID UCSD-733
Status Completed
Phase Phase 2
First received October 18, 1999
Last updated June 23, 2005
Start date February 1996

Study information

Verified date January 2000
Source Office of Rare Diseases (ORD)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

OBJECTIVES: I. Determine the effects of aminoimidazole carboxamide riboside (AICAR) on hematologic manifestations of Lesch-Nyhan disease.

II. Assess the behavioral and neurological benefits of AICAR in patients with Lesch-Nyhan disease.

III. Examine the effect of AICAR on purine production.


Description:

PROTOCOL OUTLINE:

After a 3-day baseline, patients are treated with aminoimidazole carboxamide riboside (AICAR) by continuous infusion for 12 days. Concurrent allopurinol and folate are allowed.


Recruitment information / eligibility

Status Completed
Enrollment 2
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility PROTOCOL ENTRY CRITERIA:

--Disease Characteristics-- Men with Lesch-Nyhan syndrome Moderate erythrocyte macrocytosis No active urinary tract disease or impaired renal function

Study Design

Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
aminomidazole carboxamide riboside


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
National Center for Research Resources (NCRR) University of California, San Diego

References & Publications (2)

Page T, Barshop B, Yu AL, Nyhan WL. Treatment of Lesch-Nyhan syndrome with AICAR. Adv Exp Med Biol. 1994;370:353-6. — View Citation

Page T, Barshop BA, Yu A, et al.: Treatment of Lesch-Nyhan syndrome with AICAR. In: Sahota A, Tayor M, eds.: Purine and Pyrimidine Metabolism in Man VIII. Plenum Press, New York, NY: 1995, pp 353-356.

See also
  Status Clinical Trial Phase
Recruiting NCT05548751 - Physiotherapy Assessment Based on the ICF Model in The Lesch-Nyhan Syndrome: Case Report